Prasol Chemicals is set to launch its ₹500 crore initial public offering on September 8, 2026, with a price band of ₹643–₹676 per share. Brokerage Anand Rathi has recommended a 'Subscribe for Long Term' rating, highlighting the firm's diversified chemical portfolio. Investors should evaluate both the growth potential and risks related to raw material costs and manufacturing concentration.
Prasol Chemicals is scheduled to open its initial public offering (IPO) for public subscription on September 8, 2026, with the window closing on September 10, 2026. The company has set a price band of ₹643 to ₹676 per share for the issue, which aims to raise a total of ₹500 crore. This amount includes a fresh issue of shares worth ₹80 crore and an Offer for Sale (OFS) of ₹420 crore. The shares are tentatively expected to list on the stock exchanges on September 16, 2026.
Financial and Business Overview
For the financial year ending March 2026, the company reported a revenue of ₹1,237.85 crore and a net profit of ₹83.12 crore. The business model is centered on a diverse product portfolio exceeding 150 items. These products cater to five major industrial segments: performance chemicals, paints and inks, pharmaceuticals, agrochemicals, and personal care. This cross-industry utility is often cited as a defensive mechanism, as it helps the company avoid heavy reliance on the demand cycles of any single industry.
Anand Rathi, in its latest report, has assigned a 'Subscribe for Long Term' rating to the IPO. The brokerage highlighted that the company’s ability to leverage complex chemistries and maintain a global export footprint makes it a notable candidate for long-term investors. The firm’s reach across 69 countries is viewed as a factor that provides stability against regional economic downturns.
Key Risks to Consider
While the company has shown growth, potential investors should be aware of several material risks. A primary concern for the chemical sector is the dependency on global crude oil prices, which can cause significant fluctuations in raw material costs and impact profit margins. Additionally, the company faces manufacturing concentration risk, meaning that any operational disruption at its specific production facilities could hinder its ability to fulfill orders.
Investors should also note the presence of contingent liabilities mentioned in the company's financial records. These are potential future financial obligations that could arise from past events. Furthermore, the company’s supply chain is sensitive to geopolitical tensions, particularly in West Asia, which can disrupt the flow of raw materials or finished goods.
Moving forward, the company’s performance will depend on its ability to maintain margins despite volatile input costs and its success in executing its expansion plans. Market participants will likely track how the company balances its debt management and operational efficiency in the periods following the listing.